Wiley Blackwell

SHERPA: Unknown

People

  1. Postow
    Postow
  2. Panageas
    Panageas
  3. Houghton
    Houghton
  4. Shoushtari
    Shoushtari
  5. D'Angelo
    D'Angelo
  6. Dickson
    Dickson
  7. Harding
    Harding
  8. Krown
    Krown
  9. Blasberg
    Blasberg
  10. Bluth
    Bluth

Groups

  1. Department of Medicine (39)
  2. GSK Faculty (39)
  3. Melanoma and Immunotherapeutics Service (39)
  4. Solid Tumor Oncology Division (39)
  5. Hematologic Malignancies, Division of (10)
  6. Melanoma Disease Management Team (10)
  7. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (9)
  8. Biostatistics Service (5)
  9. Epidemiology and Biostatistics (5)
  10. Population Sciences Research Program (5)
Search Within
  1. "Jedd Wolchok"
Formats
  1. Meeting Abstract (22)
  2. Journal Article (16)
  3. Book Section (1)
Groups
  1. Department of Medicine (39)
  2. GSK Faculty (39)
  3. Melanoma and Immunotherapeutics Service (39)
  4. Solid Tumor Oncology Division (39)
  5. Hematologic Malignancies, Division of (10)
  6. Melanoma Disease Management Team (10)

More Groups

People
  1. Jedd Wolchok (39)
  2. Michael Postow (10)
  3. Paul Chapman (9)
  4. Katherine Panageas (5)
  5. Margaret Callahan (5)
  6. Alan Houghton (4)

More People

Years
  1. 2023 (2)
  2. 2021 (1)
  3. 2018 (3)
  4. 2017 (3)
  5. 2016 (7)
  6. 2015 (4)

More Years

Publications
  1. Asia-Pacific Journal of Clinical Oncology (18)
  2. Cancer (5)
  3. Pigment Cell & Melanoma Research (5)
  4. Cancer Science (2)
  5. Journal Der Deutschen Dermatologischen Gesellschaft (2)
  6. Cancer Medicine (1)

More Publications

Results (39)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of tumor metabolism on the microenvironment and response to immunotherapy
    Meeting Abstract

    Zappasodi, R.; Serganova, I.; Brunschvig, S.; Santhella, A.; Mane, M.; Vemuri, K.; Ijoma, J.; Kang, W.; Manovatodorova, K.; Koutcher, J.; more...
    Cancer Science (2023)

    Fulltext@MSK | Save
  • Beyond the 5-year milestone: Long-term survivorship of melanoma patients treated off-trial with anti-PD-1
    Journal Article

    Loo, K.; Kalvin, H. L.; Panageas, K. S.; Callahan, M. K.; Chapman, P. B.; Momtaz, P.; Shoushtari, A. N.; Wolchok, J. D.; Postow, M. A.; Warner, A. B.
    Pigment Cell & Melanoma Research (2023)

    Fulltext@MSK | Save
  • Checkpoint blockade therapy for melanoma: Combinations to improve outcomes
    Meeting Abstract

    Wolchok, J.
    Asia-Pacific Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Checkpoint blockade
    Book Section

    Proverbs-Singh, T. A.; Wolchok, J.; Snyder, A.
    In Cooper, L. J. N.; Mittendorf, E. A.; Moyes, J.; Prabhakaran, S. (Eds.) Immunotherapy in Translational Cancer Research (2018)

    Fulltext@MSK | Save
  • Immune suppressive mechanism of corticosteroids used for immune-related adverse events
    Meeting Abstract

    Maeda, Y.; Tokunaga, A.; Sugiyama, D.; Warner, A. B.; Wolchok, J. D.; Nishikawa, H.
    Cancer Science (2018)

    Fulltext@MSK | Save
  • Peripheral blood clinical laboratory variables associated with outcomes following combination nivolumab and ipilimumab immunotherapy in melanoma
    Journal Article

    Rosner, S.; Kwong, E.; Shoushtari, A. N.; Friedman, C. F.; Betof, A. S.; Brady, M. S.; Coit, D. G.; Callahan, M. K.; Wolchok, J. D.; Chapman, P. B.; more...
    Cancer Medicine (2018)

    Fulltext@MSK | Save
  • Pilot study of safety and feasibility of DNA microseeding for treatment of spontaneous canine melanoma
    Journal Article

    Zuleger, C. L.; Kang, C.; Ranheim, E. A.; Kurzman, I. D.; Macklin, M. D.; Newton, M. A.; Wolchok, J. D.; Vail, D. M.; Eriksson, E.; Albertini, M. R.
    Veterinary Medicine and Science (2017)

    Fulltext@MSK | Save
  • Overall survival with nivolumab (NIVO) and ipilimumab (IPI) combination therapy in a phase III trial of advanced melanoma (CHECKMATE 067)
    Meeting Abstract

    Larkin, J.; Chiarion-Sileni, V.; Gonzalez, R.; Rutkowski, P.; Grob, J. J.; Cowey, C. L.; Lao, C. D.; Schadendorf, D.; Ferrucci, P. F.; Smylie, M.; more...
    Asia-Pacific Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Characterisation of complete responses (CRs) in patients with advanced melanoma (MEL) who received the combination of nivolumab (NIVO) and ipilimumab (IPI), NIVO, or IPI alone
    Meeting Abstract

    Robert, C.; Larkin, J.; Ascierto, P. A.; Long, G. V.; Hassel, J. C.; Schadendorf, D.; Hodi, F. S.; Lebbe, C.; Grob, J. J.; Grossmann, K.; more...
    Asia-Pacific Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Safety profile of nivolumab (NIVO) and ipilimumab (IPI) combination therapy in patients with advanced melanoma (MEL)
    Meeting Abstract

    Sznol, M.; Ferrucci, P.; Hogg, D.; Atkins, M.; Wolter, P.; Guidoboni, M.; Lebbe, C.; Kirkwood, J.; Schachter, J.; Daniels, G.; more...
    Asia-Pacific Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save